Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of Washington's demand for sensitive data.
This move was revealed following a government memo dated December was disclosed, which showed President Emmerson Mnangagwa felt the arrangement was "skewed".
An official spokesperson later explained that the US was demanding access to genetic material for research and profit but was not willing to share the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable task of ending our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for continued talks to reach a agreement acceptable to all parties so the country's critical HIV programme can proceed.
Wider Implications
Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a high court blocked a similar health funding agreement after legal challenges were filed about the security of citizens' medical information.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had managed aid for the US government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing government-to-government deals to boost openness and accountability.
Based on statements, Sixteen African countries have so far signed similar agreements, representing more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment through US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the final treatments would be accessible to our citizens if a new health crisis arise."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one deals were upending structures previously established through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system created to manage potential pandemics.
"This mechanism is intended to guarantee that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to create them."
These objections over the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage further discussions with our American counterparts on how subsequent co-operation might be structured in a way that honours the sovereignty and dignity of both nations."
Medical Community Reaction
A leading public health body stated it acknowledged the government's concerns, but urged that talks must proceed considering a large portion of the nation's HIV programmes depended on external financing.
"In cases where specific concerns exist, including those involving information security or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," it added.
The situation highlights the continuing challenges between receiving crucial international aid and protecting national sovereignty in an increasingly interconnected world.